Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM6WT8Agents primarily affecting blood constituents or immune system
Natural blood and blood products
XM1596Blood substitutes and plasma protein fractions

XM6YJ2 category

Oxypolygelatin

Also indexed as

Oxypolygelatin

Nearby in Blood substitutes and plasma protein fractions

XM84Y1Other plasma protein fractions
XM0CQ3Gelatin agents
XM8BW6Hemoglobin crosfumaril
XM4MK5Hemoglobin raffimer
XM6W72Hemoglobin glutamer
XM3CZ0Dextran
XM1H99Plasma protein fraction, human
XM6KC5Albumin

PreviousXM8H48 — Hydroxyethylstarch NextXM8UH8 — Polyvinylpyrrolidone

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM3MU3Agents primarily affecting the gastrointestinal system
XM6WT8Agents primarily affecting blood constituents or immune system
XM3KY1Agents affecting genitourinary system, sex or anabolic hormones
XM26S4Hormones and their synthetic substitutes or antagonists, not elsewhere classified
XM9W63Agents affecting bones, joints or other connective tissue, not elsewhere classified
XM4TG8Agents primarily affecting water and nutrition-balance or metabolism
XM3973Agents primarily affecting the cardiovascular system
XM6CH2Drugs primarily affecting the autonomic nervous system
XM7YD4Drugs used in addictive disorders
14 more
Immunosuppressive agents
Anticoagulants and antithrombotics
Other fibrinolysis-affecting drugs
Anticoagulant antagonists, vitamin K and other coagulants
Natural blood and blood products
Iron and its compounds
Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
Enzymes
Drugs used in hereditary angioedema
4 more
XM6HF0Human albumin
XM0XT3Natural blood (product)
XM3YQ9Normal serum albumin, salt-poor (human)
XM8TU6Whole blood (human)
XM1596Blood substitutes and plasma protein fractions
XM8K98Hematin
XM3P96Factor VIII inhibitor bypassing activity
XM58W5Coagulation factor VII
XM1UV6Coagulation factor XIII
28 more
XM84Y1Other plasma protein fractions
XM0CQ3Gelatin agents
XM8BW6Hemoglobin crosfumaril
XM4MK5Hemoglobin raffimer
XM6W72Hemoglobin glutamer
XM3CZ0Dextran
XM1H99Plasma protein fraction, human
XM6KC5Albumin
XM8H48Hydroxyethylstarch
XM6YJ2Oxypolygelatin
XM8UH8Polyvinylpyrrolidone

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact